E. Encarnacion and R. Hauser, Levodopa-Induced Dyskinesias in Parkinson’s Disease: Etiology, Impact on Quality of Life, and Treatments, European Neurology, vol.60, issue.2, pp.57-66, 2008.
DOI : 10.1159/000131893

A. Schrag, Y. Ben-shlomo, R. Brown, C. Marsden, and N. Quinn, Young-onset Parkinson's disease revisited???clinical features, natural history, and mortality, Movement Disorders, vol.5, issue.6, pp.885-94, 1998.
DOI : 10.1002/mds.870130605

M. Hely, J. Morris, W. Reid, O. Sullivan, D. Williamson et al., The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa., Journal of Neurology, Neurosurgery & Psychiatry, vol.57, issue.8, pp.903-913, 1994.
DOI : 10.1136/jnnp.57.8.903

J. Montastruc, O. Rascol, J. Senard, and A. Rascol, A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up., Journal of Neurology, Neurosurgery & Psychiatry, vol.57, issue.9, pp.1034-1042, 1994.
DOI : 10.1136/jnnp.57.9.1034

U. Rinne, Lisuride, a dopamine agonist in the treatment of early Parkinson's disease, Neurology, vol.39, issue.3, pp.336-345, 1989.
DOI : 10.1212/WNL.39.3.336

G. Parkinson-study, Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease, JAMA, vol.284, issue.15, 2000.
DOI : 10.1001/jama.284.15.1931

U. Rinne, F. Bracco, C. Chouza, E. Dupont, O. Gershanik et al., Early Treatment of Parkinson??s Disease with Cabergoline Delays the Onset of Motor Complications, Drugs, vol.55, issue.Supplement 1, pp.23-30, 1998.
DOI : 10.2165/00003495-199855001-00004

O. Rascol, D. Brooks, A. Korczyn, D. Deyn, P. Clarke et al., A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or Levodopa, New England Journal of Medicine, vol.342, issue.20, pp.1484-91, 2000.
DOI : 10.1056/NEJM200005183422004

J. Bower, D. Maraganore, S. Mcdonnell, and W. Rocca, Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990, Neurology, vol.52, issue.6, pp.1214-1234, 1999.
DOI : 10.1212/WNL.52.6.1214

A. Durocher, Consensus conference: methodology and contribution, Therapie, vol.49, pp.185-90, 1994.

M. Rosa, J. Ferreira, M. Coelho, R. Freire, and C. Sampaio, Prescribing patterns of antiparkinsonian agents in Europe, Movement Disorders, vol.3, issue.8, pp.1053-60, 2010.
DOI : 10.1002/mds.23038

G. Trifirò, R. Savica, L. Morgante, N. Vanacore, M. Tari et al., Prescribing pattern of anti-Parkinson drugs in Southern Italy: Cross-sectional analysis in the years 2003???2005, Parkinsonism & Related Disorders, vol.14, issue.5, pp.420-425, 2008.
DOI : 10.1016/j.parkreldis.2007.10.010

H. Askmark, K. Antonov, and S. Aquilonius, The increased utilisation of dopamine agonists and the introduction of COMT inhibitors have not reduced levodopa consumption???a nation-wide perspective in Sweden, Parkinsonism & Related Disorders, vol.9, issue.5, pp.271-277, 2003.
DOI : 10.1016/S1353-8020(02)00117-7